Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trumenba Immunogenicity in High-Risk Adults
NCT02569632Phase 4Completed
- Sponsor
- UCSF Benioff Children's Hospital Oakland
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group B vaccine in meningococcal infection, sponsored by UCSF Benioff Children's Hospital Oakland. Started Jan 2015; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT02569632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569632.